Read news.
KPWHRI has led the phase 1 clinical trial of the NIH-Moderna COVID-19 vaccine, giving the first shots in the world. News media interview one of the participants.
Read article.
Katharine Bradley, MD, MPH, is quoted on findings published in JAMA Network Open that following bariatric surgery, a person’s risk of developing unhealthy drinking patterns is increased, regardless of whether or not they were unhealthy drinkers before having weight-loss surgery. Bradley is the study’s senior author.
Read story.
Kaiser Permanente Washington vaccine program head and KPWHRI adjunct researcher John Dunn, MD, MPH, and KPWA physician Colin Fields, MD, who is working on KPWHRI COVID-19 vaccine trials, are interviewed about the NIH-Moderna COVID-19 vaccine.
Read story.
Lisa Jackson, MD, MPH, is quoted on the FDA Emergency Use Authorization for the COVID-19 vaccine, which was developed by Moderna and the National Institutes of Health and first tested in a phase 1 clinical trial at KPWHRI.
Read editorial.
Dan Cherkin, PhD, is interviewed about his editorial in JAMA Network about new research on how mindfulness exercises may affect migraine headaches.
Read story.
A blog hosted by the National Institute of Diabetes and Digestive and Kidney Diseases posted a Q&A with David Arterburn, MD, MPH, about his research comparing the effectiveness of 2 types of bariatric surgery for people with type 2 diabetes.
Read the bio page for Dr. Eric Larson
Eric B. Larson, MD, MPH, offers some surprising thoughts about the benefits of reminiscing with people who have dementia about their memories from young adulthood.
Read story
Interviewed about a new study showing a decline in cancer screening since measures were enacted to slow the spread of COVID-19, Diana Buist, PhD, MPH, explains how home screening for certain cancers could potentially reach people who are under-screened. Buist has done extensive research on home screening for cancer, though she was not involved in the study referenced in the story.
Read story.
The interim Data Safety Monitoring Board announced interim findings from the phase 3 trial of the NIH-Moderna vaccine for COVID-19. Lisa A. Jackson, MD, MPH, is quoted in one story, and KPWHRI is noted in another for its role in testing the vaccine.
Read news.
Eric B. Larson, MD, MPH, shares steps that everyone can take to prevent memory loss and discusses the SMARRT Study
Read news.
KPWHRI was chosen to conduct the first trial of a COVID-19 vaccine because of its experience as an NIH Vaccine and Treatment Evaluation Unit, explains Colin Fields, MD, a Kaiser Permanente Washington physician who worked on the trial in the story below. The article profiles 3 volunteers whom KPWHRI enrolled in the study.
Read news
Lisa Jackson, MD, MPH, talks about KPWHRI’s plan to enroll participants in a phase 3 clinical trial for a COVID-19 vaccine developed by Janssen Pharmaceuticals.
Read story.
Sascha Dublin, MD, PhD, MPH, discusses research by her and colleagues on the risks of pregnant women who are identified as prediabetic in their first trimester developing gestational diabetes and on the effect it will have on birth. the annual challenge of developing an influenza vaccine and why it makes sense to get vaccinated:
Read Live Healthy story
In his column, Eric Larson, MD, MPH, discusses how to improve balance through exercise that people can do even with the social distancing required in the pandemic. He quotes Ben Balderson, PhD.
Read news.
Katie Coleman, MSPH, and Cara Lewis, PhD, will co-direct a national network that supports work to address members’ social health effectiveness of the MI-CARE (More Individualized Care: Assessment and Recovery through Engagement) program.
Read story.
The Indiana University School of Medicine, the Regenstrief Institute, and Kaiser Permanente Washington Health Research Institute are launching a 4 year, $4 million pilot to study the effectiveness of the MI-CARE (More Individualized Care: Assessment and Recovery through Engagement) program.
Read story.
Michael L. Jackson, PhD, MPH, discusses the annual challenge of developing an influenza vaccine and why it makes sense to get vaccinated:
Read news.
Beverly B. Green, MD, MPH, reported results from 2 studies on diagnosing hypertension (high blood pressure) at an American Heart Association conference in September. Her presentations described trial findings about automated office blood pressure monitoring for diagnosing hypertension, and clinician and medical staff perceptions about measuring blood pressure to confirm diagnoses.
Read story
Lisa A. Jackson, MD, MPH, has conducted numerous vaccine studies, but the task before her in March was different — the timing compressed, the stakes higher — when her team launched one of the first human clinical trials for a vaccine to block infection from the virus that causes COVID-19. In the face of a global pandemic, this vaccine represented hope.
Read story.
A phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults, according to an article in The New England Journal of Medicine. Lisa A. Jackson, MD, MPH, leads the phase 1 trial at KPWHRI and is a co-author of the paper.
Read about KPWHRI adjunct researchers
Andrea J. Hoopes, MD, MPH, an adolescent medicine physician at Washington Permanente Group and an adjunct research at KPWHRI, was recognized as one of “40 under 40” influencers in the Seattle area.
Read NIAID news release.
KPWHRI is participating in phases 1 and 3 trials of an investigational messenger RNA vaccine for the COVID-19 virus. Colin Fields, MD, a Kaiser Permanente Washington clinician who works with KPWHRI’s vaccine team, explains mRNA and explores what makes this vaccine special:
Read story.
Elena Kuo, PhD, describes her research showing the potential of well-designed playgrounds to have a sustained positive effect on children’s physical activity:
Read story.
Kai Yeung, PharmD, PhD, published in the New England Journal of Medicine that state-mandated caps on out-of-pocket costs for specialty drugs reduced spending by patients with the highest bills by 32% and did not result in increases spending by health plans:
Read story.
Eric B. Larson, MD, MPH, contributed to a Lancet on dementia prevention, intervention, and care. They say up to 40% of the world’s dementia cases are linked to a handful of risk factors. Tackling those factors could help prevent or delay the onset of the disease:
Eric B. Larson, MD, MPH, writes about a silver lining of the COVID-19 pandemic: With more awareness of our inevitable mortality, more people are preparing advance care directives that truly express what they want, and don’t want, for late-life care and end of life.
Read story.
Eric B. Larson, MD, MPH, contributed to a Lancet on dementia prevention, intervention, and care. They say up to 40% of the world’s dementia cases are linked to a handful of risk factors. Tackling those factors could help prevent or delay the onset of the disease:
Read NIAID news release.
A large phase 3 efficacy trial of an investigational mRNA vaccine for the COVID-19 virus is starting, and the 89 study sites are anticipated to include KPWHRI, which launched the phase 1 trial of this vaccine:
Read news release.
An investigational mRNA vaccine designed to protect against COVID-19 was generally well tolerated and prompted neutralizing activity in healthy adults, according to interim results from a phase 1 trial published in the New England Journal of Medicine by lead author Lisa A. Jackson, MD, MPH, and colleagues:
Read story.
A large phase 3 efficacy trial of an mRNA vaccine for the COVID-19 virus will start this month and will include Kaiser Permanente Washington Health Research Group (KPWHRI), which launched the phase 1 trial of this vaccine:
Read news release.
The Allen Institute for Brain Science has teamed up with UW Medicine and KPWHRI’s Adult Changes in Thought (ACT) study to explore how Alzheimer’s disease happens in the brain:
Read blog.
A UW School of Nursing researcher describes analyzing data from the joint KPWHRI-UW ACT study, to better understand the relationship between neighborhoods and cognitive health:
Read story.
Aruna Kamineni, PhD, and Diana Buist, PhD, were among epidemiologists talking about when they’d send their children to school or camp during the pandemic; and Mike Jackson, PhD, cautioned that the less-than-scientific methods of “superforecasters” make it hard to vet their work:
Read story.
A large phase 3 efficacy trial of an mRNA vaccine for the COVID-19 virus will start this month and will include Kaiser Permanente Washington Health Research Group (KPWHRI), which launched the phase 1 trial of this vaccine:
Read news release.
Led by Michael Parchman, MD, MPH, researchers at Kaiser Permanente and the University of Washington have developed an innovative program to provide primary care clinics with practice support to reduce patients’ use of opioids:
Read blog.
Dori Rosenberg, PhD, helped older people to stand and walk more:
Read story.
Lisa A. Jackson, MD, MPH, is leading the first-ever clinical trial of any experimental vaccine targeting the virus that causes COVID-19. Moderna, Inc., produced the vaccine in record time. The National Institute of Allergy and Infectious Diseases is sponsoring the trial, which is taking place at KPWHRI’s Vaccine and Treatment Evaluation Unit. This groundbreaking research is continuing to be widely covered by media outlets around the world, including these:
Katie Coleman, MSPH, and Brian Austin discuss the multidisciplinary effort needed to optimize care and control costs for people with multiple chronic illnesses:
Read story.
Rita Mangione-Smith, MD, MPH, describes how premature hype surrounding possible therapies for COVID-19 may be hastening another long looming public health threat, overprescribing of the antibiotic azithromycin (with hydroxychloroquine)—possibly resulting in increasing bacterial resistance:
Read story.
With University of Washington colleagues and Kaiser Permanente Washington data, KPWHRI researchers are helping to find how artificial intelligence (AI) can be used to increase the accuracy of single-radiologist assessments of mammograms:
Read story.
Greg Simon, MD, MPH, explores the kind of depression that can follow an event that leaves a person feeling chronically stressed, upset, or bereaved—and how to treat it:
Read story.
Eric B. Larson, MD, MPH, says an update to the Lancet Commission on Dementia Prevention, Intervention, and Care will include pollution as one of the modifiable life-course risk factors:
Read story.
Led by Lisa A. Jackson, MD, MPH, the first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded to include older adults:
Read story.
Lisa A. Jackson, MD, MPH, is leading the first-ever clinical trial of any experimental vaccine targeting the virus that causes COVID-19. Moderna, Inc., produced the vaccine in record time. The National Institute of Allergy and Infectious Diseases is sponsoring the trial, which is taking place at KPWHRI’s Vaccine and Treatment Evaluation Unit. This groundbreaking research is continuing to be widely covered by media outlets around the world, including these:
Read story.
Rita Mangione-Smith, MD, MPH, advises parents on how to avoid the overuse of antibiotics in children:
Read story.
Eric B. Larson, MD, MPH, says alternative and complementary practices may reduce many of the symptoms of people with dementia, including anxiety and depression:
Read story.
Beverly Green, MD, MPH, is featured for her research on increasing colorectal cancer screening rates through mailing home-testing FIT kits to patients:
Read story.
Lisa A. Jackson, MD, MPH, is leading the first-ever clinical trial for a vaccine targeting the virus that causes COVID-19. Moderna, Inc., produced the vaccine in record time. The National Institute of Allergy and Infectious Diseases is sponsoring the trial, which is taking place at KPWHRI’s Vaccine and Treatment Evaluation Unit. This groundbreaking research is being widely covered by media outlets around the world, including these:
National, Mar 16, 2020:
Local, Mar 16, 2020:
International, Mar 16, 2020:
Joseph E. Glass, PhD, MSW, and Katharine Bradley, MD, MPH, are among 3 coauthors of a blog on contingency management, a behavioral treatment based on operant conditioning principles. Most often, it means providing something of monetary value to patients to incent them to not use drugs:
Watch KPWHRI video.
In this new PCORI video, David Arterburn, MD, MPH, shares the main findings of the PCORnet® Bariatric Study, which compared risks and benefits of the most common types of bariatric surgery to help patients with obesity make informed choices with their physicians:
Read the NIH trial description and the KPWHRI enrollment web page.
The first clinical trial for a vaccine targeting SARS-CoV-2, which causes COVID-19, will be sponsored by the National Institute of Allergy and Infectious Diseases. The trial will take place at KPWHRI’s Vaccine and Treatment Evaluation Unit, led by Lisa A. Jackson, MD, MPH:
Read news release.
David Arterburn, MD, MPH, was interviewed about the rise in second operations after weight-loss surgery:
Read story.
Karen Sherman, PhD, was interviewed about Medicare soon offering coverage for acupuncture treatments for lower back pain:
Read story.
The AHRQ posted a step-by-step guide to support clinics as they implement effective, guideline-driven care for their patients with chronic pain who are using opioid therapy. Michael Parchman, MD, MPH, led the team that developed Six Building Blocks: A team-based approach to improving opioid management in primary care:
Read story.
Commenting on a study linking sleep problems to cognitive decline and dementia, Eric B. Larson, MD, MPH, cautioned against overreacting with anxiety, because just because a person struggles with sleep, it doesn’t mean they’re destined to have cognitive problems:
Read story.
“Super-agers”—people who age in an unusually healthy way—tend to proactively build a lot of positive, healthy, social activity into their daily lives, according to Eric B. Larson, MD, MPH:
Read story.
KPWHRI’s Center for Community Health and Evaluation found that Washington state’s Accountable Communities of Health (ACH) have evolved into robust, regional organizations that are integral to advancing the state’s health system transformation efforts:
Read story.
Dan Cherkin, PhD, is interviewed about the issues surrounding back pain, including its causes, treatments and costs:
Our goal is to make your job easier. We can quickly arrange for you to interview our scientists about their research or the work of others. We can also provide news releases, photographs, videos, and backgrounders—and access to patients who participate in our research and would like to be interviewed.
Media contact
For more on Kaiser Permanente Washington Health Research Institute news, please contact:
Caroline Liou
Caroline.X.Liou@kp.org
206-200-4512
After-hours media line: (206) 287-2055
@KPWaResearch
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.